In Vitro Metabolic Study of Temsirolimus: Preparation, Isolation, and Identification of the Metabolites-Reference-Cited by-同舟云学术

In Vitro Metabolic Study of Temsirolimus: Preparation, Isolation, and Identification of the Metabolites

Published:2007-05-31 Issue:9 Volume:35 Page:1554-1563
ISSN:0090-9556
Container-title:Drug Metabolism and Disposition
language:en
Short-container-title:Drug Metab Dispos

Author:

Cai Ping,Tsao Rushung,Ruppen Mark E.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmaceutical Science,Pharmacology

Reference14 articles.

1. Phase II Trial of Temsirolimus (CCI-779) in Recurrent Glioblastoma Multiforme: A North Central Cancer Treatment Group Study

2. Characterization of Human Microsomal Cytochrome P-450 Enzymes

3. Holt DW, Lee TD, Mckeown DA, Hicks D, Cai P, and Johnston A (2003) Relative proportions of sirolimus (rapamycin) metabolites in blood following kidney transplantation, in Proceedings of the 8th International Congress of Therapeutic Drug Monitoring and Clinical Toxicology; 2003 Sept 7-11; Basel, Switzerland. International Association of Therapeutic Drug Monitoring and Clinical Toxicology, Kingston, ON, Canada.

4. Effects of imidazole derivatives on cytochromes P450 from human hepatocytes in primary culture

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rhabdomyosarcoma: Current Therapy, Challenges, and Future Approaches to Treatment Strategies;Cancers;2023-11-02

2. Rapalogues as hCES2A Inhibitors: In Vitro and In Silico Investigations;European Journal of Drug Metabolism and Pharmacokinetics;2020-11-02

3. Temsirolimus metabolic pathways revisited;Xenobiotica;2019-10-23

4. Targeting Protein–Protein Interactions in the Ubiquitin–Proteasome Pathway;Protein-Protein Interactions in Human Disease, Part A;2018

5. Clinical development of mTor inhibitors for renal cancer;Expert Opinion on Investigational Drugs;2017-10-03